Deccan Health Care FY26 net profit rises 91% to ₹229.05 lakh
Deccan Health Care Limited reported a 91.2% increase in standalone net profit to ₹229.05 lakh for FY26, with revenue rising 18.7% to ₹8,917.10 lakh. The board approved the audited results on May 30, 2026, which were published on June 01, 2026. Consolidated net profit for the year stood at ₹248.76 lakh.
*this image is generated using AI for illustrative purposes only.
Deccan Health Care Limited reported a 91.2% increase in net profit to ₹229.05 lakh for the financial year ended March 31, 2026, compared to ₹13.60 lakh in the previous year. Revenue from operations for the year rose 18.7% to ₹8,917.10 lakh from ₹7,513.19 lakh in FY25. The company’s board approved the standalone and consolidated audited financial results for FY26 at a meeting held on May 30, 2026. The results were reviewed by the Audit Committee and subsequently published in newspapers on June 01, 2026, pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Financial Performance for FY26
The growth in annual profitability was supported by a rise in total income, which reached ₹8,917.97 lakh for the year ended March 31, 2026, up from ₹7,513.76 lakh in the prior year. Total expenses for FY26 increased to ₹8,612.39 lakh from ₹7,346.84 lakh in the previous year. The finance costs for the year surged to ₹36.61 lakh compared to ₹7.39 lakh in FY25.
For the quarter ended March 31, 2026, the company posted a net profit of ₹22.75 lakh, a decline from ₹95.07 lakh in the quarter ended December 31, 2025. Revenue from operations for the quarter stood at ₹2,026.49 lakh, down from ₹2,303.20 lakh in the preceding quarter.
Segment and Capital Structure
The company operates in a single segment focused on the manufacturing of nutraceutical products. Paid-up equity share capital increased to ₹2,474.92 lakh as of March 31, 2026, from ₹2,342.55 lakh in the previous year. During the year, the company issued and allotted 13,23,667 equity shares upon receipt of full consideration for share warrants. Additionally, ₹75.00 lakh received towards initial consideration for 10,00,000 warrants was forfeited due to non-exercise of the conversion option.
Consolidated Results
On a consolidated basis, net profit for FY26 rose to ₹248.76 lakh from ₹12.35 lakh in the previous year. Total consolidated revenue for the year stood at ₹8,190.48 lakh, compared to ₹7,506.36 lakh in FY25. The consolidated results include the financials of subsidiary Beyoungstore Private Limited.
Standalone Financial Results (₹ in Lakhs)
| Particulars | Year Ended Mar 31, 2026 | Year Ended Mar 31, 2025 |
|---|---|---|
| Revenue from Operations | 8,917.10 | 7,513.19 |
| Total Income | 8,917.97 | 7,513.76 |
| Total Expenses | 8,612.39 | 7,346.84 |
| Profit Before Tax | 305.58 | 166.92 |
| Net Profit | 229.05 | 13.60 |
| Earnings Per Share (Basic) | 0.93 | 0.56 |
Historical Stock Returns for Deccan Health Care
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.33% | -3.83% | +2.87% | -21.56% | -45.32% | -61.74% |
What strategies will Deccan Health Care implement to sustain the 91.2% profit growth given the sequential decline in quarterly performance?
How will the company manage the nearly five-fold surge in finance costs to prevent it from eroding future margins?
What are the growth plans for the subsidiary Beyoungstore Private Limited to contribute more significantly to consolidated revenues?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
